According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...

The FDA said in a statement that it had determined that one of the two approved vaccines, Ixchiq (Valneva SE), which contains a live, weakened version of the chikungunya virus, was responsible for 21 ...

In a U-turn from a decision two weeks ago, the FDA – citing new safety events – said the vaccine is a "danger to health".

The FDA suspends Ixchiq, the only approved chikungunya vaccine, over safety concerns, impacting its availability in the U.S.

U.S. health authorities have suspended the license for the Ixchiq vaccine against the chikungunya virus following reports of ...

A detail of a packaging of the Ixchiq chikungunya vaccine, in a pharmacy in Saint-Denis, La Réunion, is shown March 21. The ...

HealthDay News — The US Food and Drug Administration (FDA) is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq, in the United States. The move comes after reports ...

Center for Biologics Evaluation and Research (CBER) has suspended the biologics license for Valneva’s Ixchiq (Chikungunya ...

Mainland France has recorded an unprecedented rise in chikungunya cases this summer as the tiger mosquito spreads across the ...

On made-in-India innovations and tech, the price of cancer drugs, the role of preventive healthcare in making for a healthier ...

Today, the American College of Cardiology (ACC) released vaccination recommendations for adults with cardiovascular disease, ...